Latest News
Conference Coverage
AI tool reveals MS drug interactions, offers safer options
Deep learning–based methods are “useful” in screening for potential interactions both between drugs and with foods.
Latest News
High and low HDL cholesterol levels linked to dementia risk
There was no significant association between LDL cholesterol and dementia risk.
Conference Coverage
Ocrelizumab benefit confirmed in older patients with MS
Lower rates of relapse were seen in older patients taking ocrelizumab, but the risk for relapse in this age group is low.
Conference Coverage
Obesity linked to multiple ills in MS study
Subjects with excess weight progressed more rapidly and had more cognitive disability.
Conference Coverage
DMT discontinuation trial halted; MS returned in 17.8%
It’s still not clear when – or if – certain patients should take a break from MS therapy.
Rare Diseases Report 2023
The dawning age of therapy for Friedreich ataxia
The first therapy to target the underlying pathology of Friedreich ataxia was approved in 2023. Other drug and genetic therapies are in the...
Rare Diseases Report 2023
Stiff person syndrome: When a rare disorder hits the headlines
Awareness of this disorder is increasing, but clinicians are challenged to apply the proper workupto avoid wrong turns in identifying affected...
Rare Diseases Report 2023
Guillain-Barré syndrome: Honing treatment strategies
Classic subtypes of Guillain-Barré syndrome are varying manifestations of a shared disease process, novel insights into the disease indicate. This...
Rare Diseases Report 2023
Has prompt diagnosis of amyotrophic lateral sclerosis become urgent?
Optimism is high about improving the survival and care of ALS patients. Neurologists who don’t specialize in ALS can add to the positivity by...
From the Journals
Pragmatic solutions to ‘catastrophic’ global stroke burden
Recommendations to reduce the global burden of stroke include measures to improve surveillance, prevention, acute care, and rehabilitation.
Literature Review
New guidelines for determining brain death released
For the first time, the guidance clarifies that clinicians don’t need to obtain consent before performing a brain death evaluation, unless...